POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 65 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,376,019 | +56.6% | 1,418,317 | +15.8% | 0.00% | – |
| Q2 2023 | $2,155,237 | +38.3% | 1,224,567 | +142.0% | 0.00% | – |
| Q1 2023 | $1,558,757 | +59760.1% | 506,090 | +3.0% | 0.00% | – |
| Q4 2022 | $2,604 | -99.8% | 491,472 | +8.0% | 0.00% | – |
| Q3 2022 | $1,606,000 | +137.2% | 455,052 | +73.4% | 0.00% | – |
| Q2 2022 | $677,000 | -70.0% | 262,481 | -47.8% | 0.00% | – |
| Q1 2022 | $2,253,000 | -32.5% | 503,032 | +2.5% | 0.00% | – |
| Q4 2021 | $3,340,000 | +21.6% | 490,599 | +30.2% | 0.00% | – |
| Q3 2021 | $2,746,000 | -27.2% | 376,749 | +0.1% | 0.00% | -100.0% |
| Q2 2021 | $3,772,000 | -1.9% | 376,544 | -6.5% | 0.00% | 0.0% |
| Q1 2021 | $3,846,000 | +64.7% | 402,793 | +89.2% | 0.00% | – |
| Q4 2020 | $2,335,000 | +39.4% | 212,907 | +12.7% | 0.00% | – |
| Q3 2020 | $1,675,000 | – | 188,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |